Journal
CURRENT PATHOBIOLOGY REPORTS
Volume 5, Issue 2, Pages 207-221Publisher
SPRINGER
DOI: 10.1007/s40139-017-0141-y
Keywords
Cholestasis; Steatosis; Alcoholic liver disease; Non-alcoholic fatty liver disease; Fibrosis; Liver regeneration
Categories
Funding
- National Institutes of Health [R00AA020514]
- Center for Pediatric Genomics in Cincinnati Children's Hospital
Ask authors/readers for more resources
Purpose of review The liver is the largest internal organ and performs both exocrine and endocrine function that is necessary for survival. Liver failure is among the leading causes of death and represents a major global health burden. Liver transplantation is the only effective treatment for end-stage liver diseases. Animal models advance our understanding of liver disease etiology and hold promise for the development of alternative therapies. Zebrafish has become an increasingly popular system for modeling liver diseases and complements the rodent models. Recent findings The zebrafish liver contains main cell types that are found in mammalian liver and exhibits similar pathogenic responses to environmental insults and genetic mutations. Zebrafish have been used to model neonatal cholestasis, cholangiopathies, alcoholic liver disease, and non-alcoholic fatty liver disease. It also provides a unique opportunity to study the plasticity of liver parenchymal cells during regeneration. Summary In this review, we summarize the recent work of building zebrafish models of liver diseases. We highlight how these studies have brought new knowledge of disease mechanisms. We also discuss the advantages and challenges of using zebrafish to model liver diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available